SouthState’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
ACA
SouthState's PBYI Position: Q3 2025 in Review
SouthState sold out of Puma Biotechnology (PBYI) in Q3 2025, closing a stake of 111 shares — an estimated $381 sold.
SouthState first reported a position in PBYI in Q1 2025 and held it in 2 quarters. The position peaked at $381 in Q2 2025. 132 funds tracked by Wall St. Rank hold PBYI as of Q3 2025.
- SouthState reported no remaining Puma Biotechnology position as of Q3 2025 after selling out during the quarter.
- SouthState sold 111 Puma Biotechnology shares in Q3 2025, an estimated $381.
- SouthState first reported a position in Puma Biotechnology in Q1 2025 and held it in 2 quarters.
- SouthState's Puma Biotechnology position peaked at $381 in Q2 2025.
- 132 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2025.
Based on SouthState's 13F filing for Q3 2025, filed 5 Nov 2025.